Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-000175-17Phase 4Completed
Phase 4, open-label, single-arm trial of nevirapine in human immunodeficiency virus infection (HIV). Primary endpoint: Steady-state clearance of nevirapine. Started Apr 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-000175-17.